Recent advances in targeting the prostacyclin pathway in pulmonary arterial hypertension
Pulmonary arterial hypertension (PAH) is a severe disease characterised by increased pulmonary vascular resistance, which leads to restricted pulmonary arterial blood flow and elevated pulmonary arterial pressure. In patients with PAH, pulmonary concentrations of prostacyclin, a prostanoid that targ...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Sprog: | English |
| Udgivet: |
European Respiratory Society
2015-12-01
|
| Serier: | European Respiratory Review |
| Online adgang: | http://err.ersjournals.com/content/24/138/630.full |